DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET

Authors

  • Márcia Bianchi Universidade Federal do Rio Grande do Sul - UFRGS
  • Caroline Lemmertz Universidade Federal do Rio Grande do Sul (UFRGS)
  • Simone Leticia Raimundini Universidade Estadual de Maringá (UEM)
  • Maria Ivanice Vendruscolo Doutoranda em Educação, Universidade Federal do Rio Grande do Sul (UFRGS).

Abstract

Derivative minimize the risks of companies operating with foreign currencies and future sales. The use of these financial instruments is increasing through many Brazilian companies that don´t evidence for the lack of effective regulation. The publicly traded companies must show in the notes the risks involved in the operations, the market value and the criteria and assumptions to determine this value of financial instruments and the policies of operation and control of operations. Therefore, the goals of this study is to investigate how is the disclosure of derivatives in the financial statements. It has been done a descriptive research, analyzing the five Brazilian companies in the healthcare sector of the BM&FBovespa, from 2008 to 2012. Was observed that only two companies showed the use of derivatives in all the years analyzed and presented correctly the data sensitivity analysis and risk evaluation. The types of derivatives used by surveyed companies were: forward exchange, currency swap and call option agreement. All companies use derivatives only for hedging purposes. It is noteworthy also that none of the companies surveyed presents quantitative information of its derivatives in the notes in the form of the table contained in Instruction CVM 475 (2008b). From the data analysis, it can be inferred that firms do not fully follow applicable accounting standards, not performing sensitivity analyzes in all years, assessment and measurement of risks in all cases, and not showing adequate and sufficiently derivatives in the notes.

Keywords: Derivatives. Disclosure. Branch Health BM&FBovespa. Corporate Accounting. International Accounting Standards.

Downloads

Download data is not yet available.

Author Biographies

Márcia Bianchi, Universidade Federal do Rio Grande do Sul - UFRGS

Possui graduação em Ciências Contábeis pela Universidade Regional Integrada do Alto Uruguai e das Missões (2000), mestrado em Ciências Contábeis pela Universidade do Vale do Rio dos Sinos- UNISINOS (2005) e doutorado em Economia pela Universidade Federal do Rio Grande do Sul - UFRGS (2013). Atualmente é professora adjunta do curso de Ciências Contábeis da Universidade Federal do Rio Grande do Sul/Porto Alegre-RS. Tem experiência na área de Ciências Contábeis, atuando principalmente nos seguintes temas: controladoria, análise de custos e contabilidade societária. Atua como editora responsável da Revista ConTexto (UFRGS).

Caroline Lemmertz, Universidade Federal do Rio Grande do Sul (UFRGS)

Graduanda em Ciências Contábeis

Simone Leticia Raimundini, Universidade Estadual de Maringá (UEM)

Doutora em Administração, Universidade Federal do Rio Grande do Sul (UFRGS)

Professora do Departamento de Ciências Contábeis da Universidade Estadual de Maringá (UEM)

Maria Ivanice Vendruscolo, Doutoranda em Educação, Universidade Federal do Rio Grande do Sul (UFRGS).

Doutoranda em Educação, Universidade Federal do Rio Grande do Sul (UFRGS).

Published

29-07-2014

How to Cite

BIANCHI, M.; LEMMERTZ, C.; RAIMUNDINI, S. L.; VENDRUSCOLO, M. I. DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET. REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte, [S. l.], v. 6, n. 2, p. 282–301, 2014. Disponível em: https://periodicos.ufrn.br/ambiente/article/view/5332. Acesso em: 23 jul. 2024.

Issue

Section

ARTICLES